Registered Nurse in Maple Valley, WA Accepting Medicare

8 Registered Nurse nurses found. Showing 1 - 8

Joada Rae Schadt, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 21020 Se 256th Pl, Maple Valley, WA 98038 Phone: 425-413-0801    Fax: 425-413-2919

Marti Bunker Mueller, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 22654 Se 280th Pl, Maple Valley, WA 98038 Phone: 805-423-0025

Nura Abdi Mohamed, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 28535 Se 228th St, Maple Valley, WA 98038 Phone: 425-428-2966

Joshua Ross Dunlap, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 21320 Se 277th St, Maple Valley, WA 98038 Phone: 253-222-3156

Maryann Mumbi Gathu, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 21525 Se 254th Pl, Maple Valley, WA 98038 Phone: 206-856-6109    Fax: 206-260-3432

Ms. Christina Arnal, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 21230 Se 268th Pl, Maple Valley, WA 98038 Phone: 253-831-3474

Sabrina Christine Stephens, FNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 27203 216th Ave Se Ste D, Maple Valley, WA 98038 Phone: 425-690-3425    Fax: 425-690-9425

Ms. Cynthia Marie Hamilton, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 28214 241st Ave Se, Maple Valley, WA 98038 Phone: 253-709-4061

News Archive

Weekend reading: Seniors smoking marijuana; Same-sex marriage and public health

For Cher Neufer, a 65-year-old retired teacher, socializing with friends (all in their 60s) means using marijuana. Once a week they get together to play Texas Hold 'Em poker "and pass around a doobie," Ms. Neufer said. … Statistics suggest that more members of the older generations, like Ms. Neufer, are using marijuana.

Hay fever vaccine shows efficacy in phase IIa trial

A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.

‘New Frontiers in Neurodegenerative Disease Research' symposium to be held from Feb. 4-7

At the Keystone Symposium "New Frontiers in Neurodegenerative Disease Research," held 4-7 February in Santa Fe, New Mexico, researchers explored the processes that lead to a variety of diseases, including Alzheimer's and Lou Gehrig's disease (amyotrophic lateral sclerosis, ALS).

CHCs and primary care providers will become America's obesity 'first responders'

Community health centers (CHCs) and primary care providers working in other settings will increasingly become America's obesity "first responders," needed to provide weight-related health services as the nation continues to implement the Affordable Care Act.

Pall to share business and financial plans for end of fiscal 2013

Pall Corporation, a global leader in filtration, separation and purification, is refreshing its five-year plan originally presented to investors in October of 2008. The event will take place on December 17, 2009 from 9:00 a.m. to approximately 11:00 a.m. ET and is being webcast live.

Read more Medical News

› Verified 7 days ago